ArticleCancer research and treatment2019

Rare Mechanism of Acquired Resistance to Osimertinib in Korean Patients with EGFR-mutated Non-small Cell Lung Cancer.

Jiyun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.